Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embryo Transfer | 63 | 2024 | 526 | 10.840 |
Why?
|
Blastocyst | 41 | 2022 | 432 | 9.050 |
Why?
|
Fertilization in Vitro | 75 | 2024 | 1301 | 8.150 |
Why?
|
Oocytes | 62 | 2024 | 1168 | 8.050 |
Why?
|
Embryo Culture Techniques | 19 | 2022 | 84 | 5.090 |
Why?
|
Pregnancy Rate | 47 | 2024 | 654 | 4.450 |
Why?
|
Live Birth | 26 | 2024 | 516 | 3.950 |
Why?
|
Embryo Implantation | 21 | 2023 | 271 | 3.800 |
Why?
|
Reproductive Techniques, Assisted | 24 | 2023 | 503 | 3.580 |
Why?
|
Preimplantation Diagnosis | 14 | 2022 | 143 | 3.450 |
Why?
|
Oocyte Retrieval | 18 | 2021 | 162 | 3.270 |
Why?
|
Embryo, Mammalian | 18 | 2018 | 1674 | 3.120 |
Why?
|
Cleavage Stage, Ovum | 10 | 2018 | 44 | 3.070 |
Why?
|
Time-Lapse Imaging | 9 | 2022 | 194 | 2.960 |
Why?
|
Sperm Injections, Intracytoplasmic | 17 | 2024 | 156 | 2.950 |
Why?
|
Embryonic Development | 19 | 2022 | 719 | 2.860 |
Why?
|
Cumulus Cells | 8 | 2024 | 22 | 2.850 |
Why?
|
Aneuploidy | 13 | 2023 | 576 | 2.500 |
Why?
|
Cryopreservation | 14 | 2021 | 727 | 2.460 |
Why?
|
Infertility, Female | 14 | 2024 | 763 | 2.120 |
Why?
|
Pregnancy | 113 | 2024 | 30230 | 1.910 |
Why?
|
Progesterone | 11 | 2024 | 751 | 1.750 |
Why?
|
Culture Media | 13 | 2022 | 889 | 1.710 |
Why?
|
Infertility | 10 | 2023 | 655 | 1.690 |
Why?
|
Reproductive Medicine | 6 | 2022 | 96 | 1.680 |
Why?
|
Granulosa Cells | 8 | 2022 | 120 | 1.660 |
Why?
|
Fertility | 8 | 2022 | 770 | 1.470 |
Why?
|
Pregnancy, Multiple | 12 | 2017 | 216 | 1.460 |
Why?
|
Meiosis | 24 | 2013 | 326 | 1.330 |
Why?
|
Maternal Age | 13 | 2017 | 804 | 1.280 |
Why?
|
Ovulation Induction | 12 | 2023 | 276 | 1.240 |
Why?
|
Phenols | 8 | 2024 | 526 | 1.230 |
Why?
|
Chorionic Gonadotropin | 9 | 2023 | 457 | 1.220 |
Why?
|
Follicular Fluid | 9 | 2024 | 92 | 1.140 |
Why?
|
Pregnancy Outcome | 24 | 2022 | 2969 | 1.140 |
Why?
|
Abortion, Spontaneous | 6 | 2022 | 536 | 1.120 |
Why?
|
Quality Control | 3 | 2020 | 835 | 1.040 |
Why?
|
Endocrine Disruptors | 7 | 2024 | 264 | 1.010 |
Why?
|
Uterus | 6 | 2024 | 660 | 1.000 |
Why?
|
Vitrification | 2 | 2023 | 47 | 0.930 |
Why?
|
Fertilization | 4 | 2015 | 197 | 0.880 |
Why?
|
Benzhydryl Compounds | 6 | 2019 | 943 | 0.880 |
Why?
|
Ovarian Follicle | 9 | 2021 | 244 | 0.870 |
Why?
|
Laboratories | 2 | 2020 | 463 | 0.850 |
Why?
|
Female | 173 | 2024 | 396141 | 0.760 |
Why?
|
Blastomeres | 2 | 2011 | 29 | 0.740 |
Why?
|
Photoperiod | 1 | 2021 | 141 | 0.720 |
Why?
|
Pregnancy Reduction, Multifetal | 2 | 2010 | 16 | 0.710 |
Why?
|
Single Embryo Transfer | 5 | 2019 | 29 | 0.710 |
Why?
|
Phthalic Acids | 6 | 2024 | 485 | 0.710 |
Why?
|
Triplets | 2 | 2010 | 42 | 0.710 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2020 | 83 | 0.690 |
Why?
|
Estradiol | 15 | 2024 | 1947 | 0.680 |
Why?
|
Seasons | 2 | 2021 | 1522 | 0.620 |
Why?
|
Genetic Testing | 8 | 2022 | 3594 | 0.610 |
Why?
|
Temperature | 2 | 2021 | 2226 | 0.590 |
Why?
|
Adult | 99 | 2024 | 223088 | 0.590 |
Why?
|
Zona Pellucida | 1 | 2017 | 15 | 0.580 |
Why?
|
Humans | 177 | 2024 | 765926 | 0.580 |
Why?
|
Societies, Medical | 8 | 2013 | 3953 | 0.520 |
Why?
|
Ectogenesis | 2 | 2012 | 8 | 0.500 |
Why?
|
Luteal Phase | 3 | 2012 | 138 | 0.490 |
Why?
|
Delivery, Obstetric | 3 | 2013 | 947 | 0.480 |
Why?
|
Ovarian Diseases | 2 | 2019 | 133 | 0.460 |
Why?
|
Birth Rate | 3 | 2020 | 168 | 0.450 |
Why?
|
MicroRNAs | 8 | 2023 | 3788 | 0.430 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2005 | 640 | 0.430 |
Why?
|
Chromosome Aberrations | 5 | 2023 | 1775 | 0.430 |
Why?
|
Twins, Monozygotic | 4 | 2010 | 470 | 0.420 |
Why?
|
Retrospective Studies | 46 | 2023 | 81537 | 0.420 |
Why?
|
Oogenesis | 4 | 2021 | 125 | 0.420 |
Why?
|
Fertility Agents, Female | 3 | 2011 | 101 | 0.410 |
Why?
|
Plastics | 1 | 2012 | 116 | 0.390 |
Why?
|
Cytoskeleton | 3 | 2012 | 1178 | 0.390 |
Why?
|
Patient Identification Systems | 1 | 2012 | 75 | 0.390 |
Why?
|
Morula | 2 | 2019 | 11 | 0.380 |
Why?
|
Twins | 3 | 2013 | 340 | 0.380 |
Why?
|
Embryo Loss | 1 | 2011 | 55 | 0.360 |
Why?
|
Menotropins | 2 | 2009 | 41 | 0.360 |
Why?
|
Cell Nucleus | 4 | 2022 | 2864 | 0.360 |
Why?
|
Choline | 2 | 2012 | 511 | 0.350 |
Why?
|
Follicle Stimulating Hormone | 4 | 2012 | 731 | 0.340 |
Why?
|
Ovum | 4 | 2002 | 187 | 0.340 |
Why?
|
Coculture Techniques | 2 | 2023 | 1336 | 0.340 |
Why?
|
Microtubules | 6 | 2012 | 1062 | 0.330 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 593 | 0.320 |
Why?
|
Zygote | 3 | 2009 | 117 | 0.310 |
Why?
|
Menstrual Cycle | 3 | 2009 | 539 | 0.310 |
Why?
|
Pregnancy Trimester, First | 3 | 2010 | 917 | 0.310 |
Why?
|
Chromosomes, Human, Pair 18 | 3 | 2005 | 247 | 0.310 |
Why?
|
Cells, Cultured | 24 | 2022 | 18962 | 0.300 |
Why?
|
Physiology | 1 | 2008 | 112 | 0.300 |
Why?
|
Biopsy | 6 | 2024 | 6766 | 0.300 |
Why?
|
Cell Culture Techniques | 4 | 2013 | 1650 | 0.300 |
Why?
|
Placentation | 1 | 2008 | 78 | 0.290 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 3690 | 0.280 |
Why?
|
Oxygen | 2 | 2018 | 4246 | 0.270 |
Why?
|
Metaphase | 8 | 2012 | 143 | 0.270 |
Why?
|
Follicle Stimulating Hormone, Human | 2 | 2008 | 25 | 0.270 |
Why?
|
Cyclic AMP | 6 | 1986 | 1466 | 0.270 |
Why?
|
Chromatin | 11 | 2012 | 2979 | 0.270 |
Why?
|
Treatment Outcome | 24 | 2024 | 65194 | 0.270 |
Why?
|
Maternal Exposure | 3 | 2018 | 1098 | 0.270 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 420 | 0.270 |
Why?
|
Birth Weight | 3 | 2022 | 2122 | 0.260 |
Why?
|
Polyploidy | 1 | 2006 | 120 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2017 | 8924 | 0.250 |
Why?
|
Microscopy | 1 | 2011 | 900 | 0.250 |
Why?
|
Time Factors | 15 | 2018 | 40097 | 0.250 |
Why?
|
Organ Transplantation | 3 | 2024 | 1172 | 0.240 |
Why?
|
Checklist | 1 | 2012 | 837 | 0.240 |
Why?
|
Chromosomes | 3 | 2013 | 578 | 0.230 |
Why?
|
Infertility, Male | 2 | 2008 | 395 | 0.230 |
Why?
|
Diterpenes | 4 | 1985 | 166 | 0.230 |
Why?
|
Cohort Studies | 14 | 2022 | 41680 | 0.220 |
Why?
|
Medical Errors | 1 | 2012 | 1258 | 0.220 |
Why?
|
Endometriosis | 3 | 2022 | 869 | 0.220 |
Why?
|
Premature Birth | 3 | 2022 | 1830 | 0.220 |
Why?
|
Clomiphene | 1 | 2003 | 71 | 0.210 |
Why?
|
Software | 1 | 2017 | 4462 | 0.210 |
Why?
|
Placenta | 4 | 2023 | 1726 | 0.210 |
Why?
|
Genetic Counseling | 2 | 2023 | 634 | 0.210 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2003 | 133 | 0.200 |
Why?
|
Multiple Birth Offspring | 3 | 2011 | 22 | 0.200 |
Why?
|
Proteomics | 2 | 2006 | 3906 | 0.200 |
Why?
|
Coitus | 1 | 2022 | 133 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8721 | 0.190 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1804 | 0.190 |
Why?
|
Receptors, FSH | 1 | 2021 | 29 | 0.190 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1293 | 0.190 |
Why?
|
Mesocricetus | 10 | 1992 | 256 | 0.180 |
Why?
|
Semen | 2 | 2023 | 351 | 0.180 |
Why?
|
Placenta Previa | 1 | 2022 | 125 | 0.180 |
Why?
|
Gene Expression | 3 | 2016 | 7581 | 0.180 |
Why?
|
Infant, Newborn | 9 | 2022 | 26380 | 0.180 |
Why?
|
Databases as Topic | 3 | 2012 | 472 | 0.180 |
Why?
|
Reproduction | 2 | 2022 | 645 | 0.180 |
Why?
|
Caffeine | 2 | 2017 | 702 | 0.170 |
Why?
|
Ovary | 4 | 2019 | 961 | 0.170 |
Why?
|
Terminology as Topic | 2 | 2017 | 1536 | 0.170 |
Why?
|
Environmental Pollutants | 2 | 2021 | 1294 | 0.170 |
Why?
|
Vaccination | 2 | 2022 | 3430 | 0.170 |
Why?
|
Databases, Factual | 4 | 2015 | 8060 | 0.170 |
Why?
|
Blastocyst Inner Cell Mass | 1 | 2019 | 7 | 0.170 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 3430 | 0.160 |
Why?
|
Cell Shape | 2 | 2011 | 372 | 0.160 |
Why?
|
Vaginal Creams, Foams, and Jellies | 4 | 2012 | 62 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1393 | 0.160 |
Why?
|
Cell Division | 1 | 2006 | 4466 | 0.150 |
Why?
|
Boston | 6 | 2015 | 9334 | 0.150 |
Why?
|
Obesity | 4 | 2015 | 13082 | 0.150 |
Why?
|
Injections, Intramuscular | 4 | 2012 | 551 | 0.150 |
Why?
|
Dictionaries as Topic | 1 | 2017 | 11 | 0.150 |
Why?
|
Diethylhexyl Phthalate | 1 | 2018 | 86 | 0.140 |
Why?
|
Public Policy | 1 | 2022 | 551 | 0.140 |
Why?
|
Embryonic Stem Cells | 3 | 2012 | 1242 | 0.140 |
Why?
|
Prosthesis Failure | 1 | 2023 | 1194 | 0.140 |
Why?
|
Artifacts | 1 | 2006 | 1896 | 0.140 |
Why?
|
Cricetinae | 10 | 1992 | 2412 | 0.140 |
Why?
|
Overweight | 3 | 2015 | 2444 | 0.140 |
Why?
|
Body Mass Index | 5 | 2019 | 13042 | 0.140 |
Why?
|
Saccharomyces cerevisiae | 1 | 2008 | 2674 | 0.140 |
Why?
|
Genomic Imprinting | 1 | 2019 | 326 | 0.140 |
Why?
|
Leuprolide | 2 | 2005 | 310 | 0.140 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9525 | 0.140 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2016 | 52 | 0.130 |
Why?
|
Reference Standards | 2 | 2010 | 1011 | 0.130 |
Why?
|
Collagen | 1 | 2005 | 2616 | 0.130 |
Why?
|
Spermatozoa | 2 | 1998 | 627 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 869 | 0.130 |
Why?
|
Carbonated Beverages | 1 | 2017 | 209 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1273 | 0.130 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 530 | 0.130 |
Why?
|
Mosaicism | 1 | 2019 | 481 | 0.130 |
Why?
|
Gestational Age | 4 | 2018 | 3616 | 0.130 |
Why?
|
Microscopy, Fluorescence | 3 | 2024 | 2627 | 0.120 |
Why?
|
Young Adult | 12 | 2021 | 59857 | 0.120 |
Why?
|
Prospective Studies | 10 | 2024 | 54807 | 0.120 |
Why?
|
Body Weight | 1 | 2006 | 4627 | 0.120 |
Why?
|
Risk Assessment | 6 | 2019 | 24275 | 0.120 |
Why?
|
Fetal Growth Retardation | 2 | 2011 | 591 | 0.120 |
Why?
|
Chorion | 2 | 2008 | 113 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 10380 | 0.120 |
Why?
|
Logistic Models | 8 | 2020 | 13273 | 0.120 |
Why?
|
Cell Count | 2 | 2011 | 1823 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 1005 | 0.110 |
Why?
|
Embryonic and Fetal Development | 3 | 2003 | 420 | 0.110 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2017 | 395 | 0.110 |
Why?
|
Odds Ratio | 3 | 2017 | 9656 | 0.110 |
Why?
|
United States | 11 | 2022 | 72909 | 0.110 |
Why?
|
Random Allocation | 1 | 2018 | 2394 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10727 | 0.110 |
Why?
|
Insemination, Artificial, Homologous | 1 | 2013 | 16 | 0.110 |
Why?
|
Animals | 27 | 2024 | 168735 | 0.110 |
Why?
|
Male | 23 | 2023 | 363815 | 0.110 |
Why?
|
Coffee | 1 | 2017 | 593 | 0.100 |
Why?
|
Nicotine | 2 | 1989 | 680 | 0.100 |
Why?
|
Microscopy, Polarization | 1 | 2012 | 88 | 0.100 |
Why?
|
Embryology | 1 | 2012 | 30 | 0.100 |
Why?
|
Counseling | 2 | 2018 | 1551 | 0.100 |
Why?
|
Leadership | 1 | 2022 | 1393 | 0.100 |
Why?
|
Receptors, LH | 1 | 2012 | 18 | 0.100 |
Why?
|
Intercellular Junctions | 2 | 1990 | 198 | 0.100 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2012 | 23 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1263 | 0.100 |
Why?
|
Cytoplasm | 2 | 2010 | 1498 | 0.100 |
Why?
|
Age Factors | 7 | 2013 | 18382 | 0.100 |
Why?
|
Limit of Detection | 1 | 2012 | 271 | 0.090 |
Why?
|
Proteins | 1 | 2006 | 5994 | 0.090 |
Why?
|
Suction | 1 | 2012 | 268 | 0.090 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 267 | 0.090 |
Why?
|
Edetic Acid | 1 | 2012 | 274 | 0.090 |
Why?
|
Karyotyping | 3 | 2012 | 1175 | 0.090 |
Why?
|
Parthenogenesis | 1 | 2011 | 29 | 0.090 |
Why?
|
Placenta Accreta | 1 | 2015 | 242 | 0.090 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2012 | 204 | 0.090 |
Why?
|
Graft Rejection | 1 | 2024 | 4503 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2019 | 3606 | 0.090 |
Why?
|
Tissue Donors | 3 | 2022 | 2392 | 0.090 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2011 | 104 | 0.090 |
Why?
|
Solubility | 1 | 2012 | 1077 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2015 | 22228 | 0.090 |
Why?
|
Twinning, Monozygotic | 1 | 2010 | 17 | 0.090 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 249 | 0.090 |
Why?
|
Hospitals, University | 1 | 2012 | 573 | 0.090 |
Why?
|
Insemination, Artificial | 1 | 2011 | 99 | 0.090 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 391 | 0.090 |
Why?
|
Risk Factors | 10 | 2022 | 74850 | 0.090 |
Why?
|
Ploidies | 2 | 2021 | 287 | 0.090 |
Why?
|
Treatment Failure | 3 | 2006 | 2653 | 0.080 |
Why?
|
Twins, Dizygotic | 1 | 2010 | 236 | 0.080 |
Why?
|
Luteinizing Hormone | 2 | 2009 | 828 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 437 | 0.080 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 168 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2005 | 2510 | 0.080 |
Why?
|
Schools, Veterinary | 1 | 2008 | 7 | 0.080 |
Why?
|
International Cooperation | 3 | 2011 | 1433 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2012 | 752 | 0.080 |
Why?
|
Accreditation | 1 | 2012 | 476 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1527 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2680 | 0.080 |
Why?
|
Uterine Hemorrhage | 1 | 2010 | 235 | 0.080 |
Why?
|
Cell Communication | 5 | 1989 | 1660 | 0.080 |
Why?
|
Histones | 1 | 2019 | 2590 | 0.080 |
Why?
|
Endopeptidases | 1 | 1992 | 760 | 0.080 |
Why?
|
Cell Size | 1 | 2010 | 626 | 0.080 |
Why?
|
Adolescent | 7 | 2022 | 88811 | 0.080 |
Why?
|
Chromosomes, Human, Pair 21 | 2 | 2005 | 228 | 0.070 |
Why?
|
Oocyte Donation | 2 | 2007 | 52 | 0.070 |
Why?
|
Incidence | 6 | 2014 | 21513 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7423 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15401 | 0.070 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2007 | 46 | 0.070 |
Why?
|
Israel | 2 | 2021 | 729 | 0.070 |
Why?
|
England | 1 | 2008 | 533 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8724 | 0.070 |
Why?
|
Europe | 2 | 2012 | 3430 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1152 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2022 | 20133 | 0.070 |
Why?
|
Endocrinology | 1 | 2013 | 441 | 0.070 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2005 | 340 | 0.070 |
Why?
|
Regression Analysis | 3 | 2017 | 6321 | 0.070 |
Why?
|
Embryo Research | 1 | 2007 | 38 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3661 | 0.070 |
Why?
|
Infant, Low Birth Weight | 2 | 2015 | 870 | 0.070 |
Why?
|
Calcium Chloride | 1 | 1986 | 78 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1028 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1194 | 0.060 |
Why?
|
Cotinine | 1 | 1987 | 206 | 0.060 |
Why?
|
Patient Selection | 1 | 2018 | 4248 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5531 | 0.060 |
Why?
|
Amino Acids | 1 | 2012 | 1709 | 0.060 |
Why?
|
Maturation-Promoting Factor | 1 | 2005 | 26 | 0.060 |
Why?
|
Gonadotropins, Pituitary | 1 | 2005 | 70 | 0.060 |
Why?
|
Academic Medical Centers | 2 | 2015 | 2782 | 0.060 |
Why?
|
Hormones | 1 | 2009 | 865 | 0.060 |
Why?
|
Amniocentesis | 1 | 2005 | 116 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.060 |
Why?
|
Nuchal Translucency Measurement | 1 | 2005 | 59 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 505 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2006 | 398 | 0.060 |
Why?
|
Kinetics | 4 | 2022 | 6273 | 0.060 |
Why?
|
Tamoxifen | 2 | 1987 | 964 | 0.060 |
Why?
|
Thromboxanes | 1 | 1983 | 45 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 1992 | 4617 | 0.050 |
Why?
|
Gels | 1 | 2005 | 420 | 0.050 |
Why?
|
Thromboxane B2 | 1 | 1983 | 143 | 0.050 |
Why?
|
ROC Curve | 2 | 2015 | 3612 | 0.050 |
Why?
|
Research Design | 2 | 2010 | 6204 | 0.050 |
Why?
|
Inhibins | 1 | 2024 | 210 | 0.050 |
Why?
|
Fetal Viability | 1 | 2003 | 23 | 0.050 |
Why?
|
Specimen Handling | 1 | 1988 | 704 | 0.050 |
Why?
|
Arachidonic Acids | 1 | 1983 | 293 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4851 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4669 | 0.050 |
Why?
|
Cell Survival | 3 | 2012 | 5745 | 0.050 |
Why?
|
Gonadotropins | 2 | 2000 | 241 | 0.050 |
Why?
|
Monkeypox virus | 1 | 2022 | 43 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2003 | 238 | 0.050 |
Why?
|
Pregnancy, High-Risk | 1 | 2003 | 121 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6058 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4527 | 0.050 |
Why?
|
Prostaglandins | 1 | 1983 | 396 | 0.050 |
Why?
|
Anaphase | 2 | 1992 | 112 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3318 | 0.050 |
Why?
|
Reproductive Techniques | 1 | 2001 | 41 | 0.050 |
Why?
|
France | 1 | 2022 | 495 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3106 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2970 | 0.050 |
Why?
|
Education, Medical | 1 | 2013 | 1744 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 29890 | 0.050 |
Why?
|
Body Fluids | 1 | 1982 | 320 | 0.040 |
Why?
|
Algorithms | 3 | 2010 | 14064 | 0.040 |
Why?
|
Swine | 6 | 1988 | 5986 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2007 | 1394 | 0.040 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 1998 | 238 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2005 | 1239 | 0.040 |
Why?
|
Glucose | 1 | 2012 | 4335 | 0.040 |
Why?
|
Models, Statistical | 1 | 2014 | 5088 | 0.040 |
Why?
|
Computational Biology | 1 | 2012 | 3562 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39228 | 0.040 |
Why?
|
Labor, Induced | 2 | 1998 | 153 | 0.040 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4037 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6306 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2194 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 647 | 0.040 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2001 | 258 | 0.040 |
Why?
|
Dicarboxylic Acids | 1 | 2018 | 75 | 0.040 |
Why?
|
Heterozygote | 1 | 2005 | 2796 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8223 | 0.040 |
Why?
|
Endometrium | 2 | 2015 | 404 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 1998 | 313 | 0.040 |
Why?
|
Culture Techniques | 2 | 1989 | 515 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 1998 | 260 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2008 | 1463 | 0.040 |
Why?
|
Fetus | 1 | 2005 | 1878 | 0.040 |
Why?
|
Pedigree | 1 | 2005 | 4535 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 602 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12059 | 0.030 |
Why?
|
Fallopian Tube Diseases | 1 | 1997 | 60 | 0.030 |
Why?
|
Cosmetics | 1 | 2018 | 104 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2023 | 1142 | 0.030 |
Why?
|
Habits | 1 | 2017 | 147 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2019 | 699 | 0.030 |
Why?
|
Vocabulary, Controlled | 1 | 2017 | 170 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14643 | 0.030 |
Why?
|
PPAR gamma | 1 | 2019 | 484 | 0.030 |
Why?
|
Leiomyoma | 1 | 2001 | 644 | 0.030 |
Why?
|
Uridine | 2 | 1987 | 135 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2017 | 507 | 0.030 |
Why?
|
Androgens | 1 | 1983 | 1278 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6491 | 0.030 |
Why?
|
Dehydroepiandrosterone | 1 | 1996 | 248 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7847 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1998 | 1242 | 0.030 |
Why?
|
Alleles | 2 | 2019 | 6891 | 0.030 |
Why?
|
Isoquinolines | 2 | 1987 | 350 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1407 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2017 | 993 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3904 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26282 | 0.030 |
Why?
|
Freeze Fracturing | 2 | 1990 | 67 | 0.030 |
Why?
|
Labor, Obstetric | 1 | 1996 | 313 | 0.030 |
Why?
|
Apoptosis | 3 | 2017 | 9505 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 804 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2001 | 1772 | 0.030 |
Why?
|
Placenta Diseases | 1 | 2015 | 199 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2866 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2022 | 2192 | 0.030 |
Why?
|
Fixatives | 1 | 1992 | 90 | 0.020 |
Why?
|
Infant, Premature | 1 | 2022 | 2121 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2001 | 1425 | 0.020 |
Why?
|
Weight Gain | 1 | 2022 | 2356 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1007 | 0.020 |
Why?
|
Hazardous Substances | 1 | 2012 | 153 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2019 | 1936 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1467 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1637 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 30192 | 0.020 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2011 | 114 | 0.020 |
Why?
|
Inservice Training | 1 | 2013 | 375 | 0.020 |
Why?
|
Progesterone Congeners | 1 | 2010 | 42 | 0.020 |
Why?
|
Cell Membrane | 2 | 1989 | 3635 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3690 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 116 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2012 | 319 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 1990 | 2543 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5772 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5873 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2008 | 11639 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2011 | 780 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8882 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 223016 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2920 | 0.020 |
Why?
|
Follicular Atresia | 1 | 1988 | 7 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3669 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2012 | 391 | 0.020 |
Why?
|
Fluorescent Dyes | 2 | 1987 | 1927 | 0.020 |
Why?
|
Anesthesia, Intravenous | 1 | 2008 | 130 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5784 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3202 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 937 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1740 | 0.020 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1986 | 99 | 0.020 |
Why?
|
Bucladesine | 1 | 1986 | 117 | 0.020 |
Why?
|
Calcimycin | 1 | 1986 | 214 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13026 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2969 | 0.020 |
Why?
|
Egtazic Acid | 1 | 1986 | 165 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1987 | 405 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3431 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2021 | 4544 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1055 | 0.020 |
Why?
|
Educational Measurement | 1 | 2013 | 1260 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2393 | 0.020 |
Why?
|
Societies, Scientific | 1 | 2007 | 221 | 0.020 |
Why?
|
Chimera | 1 | 2007 | 455 | 0.020 |
Why?
|
Gonadotropins, Equine | 1 | 1985 | 7 | 0.020 |
Why?
|
Anesthesia, Spinal | 1 | 2008 | 280 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2120 | 0.020 |
Why?
|
Mammals | 1 | 1990 | 1126 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4424 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 1134 | 0.010 |
Why?
|
Lasalocid | 1 | 1983 | 6 | 0.010 |
Why?
|
Meclofenamic Acid | 1 | 1983 | 23 | 0.010 |
Why?
|
Aged | 2 | 2014 | 171163 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1156 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2037 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1984 | 2077 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2492 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7417 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 4563 | 0.010 |
Why?
|
Membrane Lipids | 1 | 1983 | 240 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1982 | 319 | 0.010 |
Why?
|
Electrophysiology | 1 | 1985 | 1264 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1983 | 429 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1985 | 1084 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2008 | 1169 | 0.010 |
Why?
|
Anesthesia, General | 1 | 2008 | 1182 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2000 | 303 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6251 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2007 | 2350 | 0.010 |
Why?
|
Dextrans | 1 | 1982 | 570 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4342 | 0.010 |
Why?
|
Informed Consent | 1 | 2007 | 1010 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2000 | 214 | 0.010 |
Why?
|
Blood | 1 | 1982 | 597 | 0.010 |
Why?
|
Diploidy | 1 | 2000 | 141 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2007 | 808 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10843 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 339 | 0.010 |
Why?
|
Phospholipids | 1 | 1983 | 776 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2000 | 610 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11895 | 0.010 |
Why?
|
Species Specificity | 1 | 1983 | 2406 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2699 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14745 | 0.010 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1767 | 0.010 |
Why?
|
Estrogens | 1 | 2004 | 1528 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2010 | 3477 | 0.010 |
Why?
|
Action Potentials | 1 | 1985 | 1837 | 0.010 |
Why?
|
Aging | 2 | 2008 | 8725 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4855 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 1998 | 298 | 0.010 |
Why?
|
Rabbits | 1 | 1983 | 4729 | 0.010 |
Why?
|
Mice | 3 | 2012 | 81782 | 0.010 |
Why?
|
Cell Death | 1 | 2000 | 1676 | 0.010 |
Why?
|
Lipids | 1 | 1986 | 3317 | 0.010 |
Why?
|
Child | 1 | 2023 | 80568 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15828 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3272 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10575 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3801 | 0.010 |
Why?
|
Calcium | 1 | 1986 | 5769 | 0.010 |
Why?
|
Parity | 1 | 1996 | 931 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15540 | 0.010 |
Why?
|
Oxytocin | 1 | 1996 | 404 | 0.010 |
Why?
|
Testosterone | 1 | 1982 | 2495 | 0.010 |
Why?
|
RNA | 1 | 2000 | 2716 | 0.010 |
Why?
|
Rats | 1 | 1984 | 23708 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11030 | 0.000 |
Why?
|
Lysophosphatidylcholines | 1 | 1986 | 77 | 0.000 |
Why?
|
Phosphatidylethanolamines | 1 | 1986 | 129 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2008 | 15802 | 0.000 |
Why?
|
Phosphatidylcholines | 1 | 1986 | 403 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12768 | 0.000 |
Why?
|
Fatty Acids | 1 | 1986 | 1804 | 0.000 |
Why?
|
Cholesterol | 1 | 1986 | 2902 | 0.000 |
Why?
|